GlassScriptPhysician profile
Michael Sichlau
NPI 1710927793
$33,338.60
in general payments reported to CMS, 2019-2025
33 companies · $1,179 in 2025
The $1,179 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $26K · 2021: $577 · 2022: $474 · 2023: $1,431 · 2024: $2,654 · 2025: $1,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,691 · Travel and Lodging: $1,572 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,691.18 |
| Travel and Lodging | $1,571.87 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $23,222.85 | 2020-2021 | |
| Boston Scientific Corporation | $3,830.87 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere360_pi, Ekosonic |
| Inari Medical, INC. | $1,203.54 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Siemens Medical Solutions USA, INC. | $1,033.51 | 2022-2025 | Embozene, Cios Spin, Acuson Maple Select Diagnostic Ultrasound System |
| Cook Incorporated | $1,022.78 | 2024 | Gunther Tulip |
| Penumbra, INC. | $323.35 | 2025 | Indigo System, Penumbra System |
| Angiodynamics, INC. | $296.04 | 2019-2024 | Alphavac |
| Stryker Corporation | $235.16 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $223.61 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $201.95 | 2021-2025 | Concertotm, Abre |
| Ge Healthcare | $179.17 | 2023 | |
| Bard Peripheral Vascular, INC. | $162.17 | 2021-2025 | Venovo |
| Veryan Medical Incorporated | $145.23 | 2024 | Biomimics 3d Vascular Stent System |
| Cook Medical LLC | $143.01 | 2021-2024 | Rosen, Zilver Vena |
| Medtronic USA, INC. | $134.94 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $127.96 | 2019-2024 | Angio-Seal, Tr Band |
| Sirtex Medical INC | $125.88 | 2025 | Sir-Spheres Microspheres |
| Lenoss Medical INC | $118.50 | 2025 | Osteopearl |
| Argon Medical Devices, INC. | $114.51 | 2023 | Ivcf |
| Philips North America LLC | $112.31 | 2019-2023 | |
| Ethicon Endo-Surgery INC. | $93.60 | 2023 | Neuwave |
| Ethicon US, LLC | $52.10 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $26.02 | 2025 | Provenge |
| Blue Earth Diagnostics | $25.00 | 2024 | |
| Imperative Care, INC | $24.64 | 2025 | Zoom 88-T Large Distal Platform |
| Myriad Genetic Laboratories, INC. | $24.06 | 2024 | Prolaris |
| Cardiva Medical, INC. | $22.72 | 2022 | |
| Shionogi INC | $22.68 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.42 | 2019 | |
| Endo USA, INC. | $19.72 | 2025 | Xiaflex |
| Janssen Pharmaceuticals, INC | $19.64 | 2022 | |
| Dova Pharmaceuticals | $17.42 | 2019 | |
| Trisalus Life Sciences, INC. | $13.24 | 2024 | Trinav Infusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$125,190.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sichlau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.